DUBLIN–(BUSINESS WIRE)–The “Global Optic Neuromyelitis Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Optic Neuromyelitis Pipeline Highlights – 2019 provides most up-to-date information on key pipeline products in the global Optic Neuromyelitis market. It covers emerging therapies for Optic Neuromyelitis in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps
Author: Business Wire
Macular Edema Clinical Trial Pipeline Highlights 2019 – Global Forecast to 2024 by Clinical Trial Stages, Drug Mechanism Classes, Company – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Macular Edema Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Macular Edema Pipeline Highlights – 2019 provides the most up-to-date information on key pipeline products in the global Macular Edema market. It covers emerging therapies for Macular Edema in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for track
Pharmaceutical Technology® Presents Webcast on Issues in Ophthalmic Drug Delivery
CRANBURY, N.J.–(BUSINESS WIRE)–<a href="https://twitter.com/hashtag/pharma?src=hash" target="_blank">#pharma</a>–Pharmaceutical Technology® Presents Webcast on Issues in Ophthalmic Drug Delivery
Noveome Biotherapeutics, Inc. Announces the First Patient Dosed in Phase 2 Open Label Clinical Trial Evaluating Topical Ocular Delivery of ST266 For the Treatment of Persistent Corneal Epithelial Defects
PITTSBURGH–(BUSINESS WIRE)–Noveome Biotherapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing next-generation biologics for the promotion and restoration of cellular integrity of inflamed or damaged tissues, today announc…
Aerie Pharmaceuticals to Present at Two Upcoming Investor Conferences
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Sheridan Capital Partners Invests in Atlantic Vision Partners
CHICAGO–(BUSINESS WIRE)–Sheridan Capital Partners (“Sheridan”) announced today its investment in Atlantic Vision Partners (“AVP” or the “Company”), a vision practice management company. In the transaction, Sheridan invested alongside AVP’s founders a…
Jon Morgan Joins Eyecare Services Partners as Chief Information Officer
DALLAS–(BUSINESS WIRE)–Eyecare Services Partners (ESP), the national leader in integrated eye care services, announced the appointment of Jon Morgan as Chief Information Officer effective today. Mr. Morgan leads Information Technology for ESP, which …
Rick Hoffner Joins Eyecare Services Partners as Vice President of Operations, Central Region
DALLAS–(BUSINESS WIRE)–Eyecare Services Partners (ESP), the national leader in integrated eye care services, announced the appointment of Rick Hoffner as Vice President of Operations for the Central Region, effective today. Mr. Hoffner will lead the …
Aerpio Initiates Phase 1b Clinical Trial of Topical Ocular Formulation of AKB-9778 for Primary Open Angle Glaucoma
CINCINNATI–(BUSINESS WIRE)–Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, today announced dosing of the first subject in…
NovaBay Pharmaceuticals Launches Avenova® Direct on Amazon.com
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova® for the domestic eye care market, announces that Avenova® Direct is available at affordable prici…
Acucela Receives Orphan Designation From the EMA for Emixustat for the Treatment of Stargardt Disease
SEATTLE–(BUSINESS WIRE)–Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced today that the European Medicines Agency (EMA) granted orphan des…
FGX International Launches “Reading Glasses Day” with RestoringVision
SMITHFIELD, R.I.–(BUSINESS WIRE)–FGX International, a leading eyewear designer and marketer, is partnering with RestoringVision to launch the first Reading Glasses Day on June 7, 2019. Reading Glasses Day is a commemorative date dedicated to raising …
Global Glaucoma Clinical Trial Pipeline Highlights, 2019 Report – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Glaucoma Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Glaucoma Pipeline Highlights – 2019, provides most up-to-date information on key pipeline products in the global Glaucoma market. It covers emerging therapies for Glaucoma in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identi
Ophthalmology Times® Now Accepting Nominations for 2019 Research Scholar Honoree Program
CRANBURY, N.J.–(BUSINESS WIRE)–<a href="https://twitter.com/hashtag/ophthalmology?src=hash" target="_blank">#ophthalmology</a>–Ophthalmology Times® Now Accepting Nominations for 2019 Research Scholar Honoree Program
Global $673.2Mn Optical Lens Edgers Market Outlook Report, 2026 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Optical Lens Edgers Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018-2026” report has been added to ResearchAndMarkets.com’s offering. The global optical lens edgers market was valued at US$ 380.5 million in 2017 and is expected to reach US$ 673.2 million by 2026, expanding at a CAGR of 6.7% from 2018 to 2026. Key Market Movements Growing senescent population and increas
Global Vision Care Market 2019-2023 – Shift to E-commerce Platforms & Growing Preference for Daily Disposable Contact Lenses – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Vision Care Market: Size, Trends and Forecast (2019-2023)” report has been added to ResearchAndMarkets.com’s offering. Global Vision Care Market: Size, Trends and Forecast (2019-2023) provides an in-depth analysis of the vision care market including a detailed description of market sizing and growth. The report provides an analysis of the global vision care market by value and by segments. The report also includes a detailed segment analysis of the vision ca
Researchers Study Improvement in Patient Compliance and Screening Efficacy by Using the EyeArt AI Eye Screening System for Detecting Diabetic Retinopathy
LOS ANGELES–(BUSINESS WIRE)–Improvement in Patient Compliance and Screening Efficacy by Using the EyeArt AI Eye Screening System for Detecting Diabetic Retinopathy
International Study Confirms Significant, Sustained IOP and Medication Reduction Following Standalone Implantation of Glaukos’ iStent inject® in Glaucoma Patients with Substantial Disease Burden
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies desig…
Allegro Ophthalmics Announces Positive Topline Vision Results of Phase 2 Study Evaluating Risuteganib in Patients with Intermediate Dry Age-Related Macular Degeneration
SAN JUAN CAPISTRANO, Calif.–(BUSINESS WIRE)–<a href="https://twitter.com/hashtag/DME?src=hash" target="_blank">#DME</a>–Allegro Ophthalmics today announced positive topline results of its U.S. Phase 2 study of risuteg…
Re-Vana Therapeutics Names Renowned International Experts to Inaugural Scientific Advisory Board
BELFAST, Northern Ireland–(BUSINESS WIRE)–<a href="https://twitter.com/hashtag/SAB?src=hash" target="_blank">#SAB</a>–Re-Vana Therapeutics, a specialty ocular pharmaceutical company focused on photo-crosslinked drug d…